Respiratory infections after lung cancer resection

Clinical Pulmonary Medicine

Volumn 13, Issue 1, 2006, Pages 8-16

  Belda, José ^a,b   Cavalcanti, Manuela ^a   Iglesias, Manuela ^a   Gimferrer, José M ^a   Torres, Antoni ^a  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Lung cancer resection; Postoperative pneumonia; Risk factors

Indexed keywords

AMOXICILLIN; CEFALOTIN; CEFAMANDOLE; CEFAZOLIN; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN; PENICILLIN G SODIUM; SULTAMICILLIN; TIMENTIN; VANCOMYCIN;

ANESTHESIA; ANTIBIOTIC PROPHYLAXIS; BACTERIAL COLONIZATION; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CLINICAL TRIAL; DRUG EFFICACY; HEALTH CARE UTILIZATION; HEART MUSCLE REVASCULARIZATION; HEART SURGERY; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; INFECTION RISK; INTENSIVE CARE UNIT; LUNG CANCER; LUNG CARCINOMA; LUNG FUNCTION; MEDICAL SOCIETY; MINIMALLY INVASIVE SURGERY; MORBIDITY; NUTRITIONAL STATUS; PATIENT SELECTION; PNEUMONIA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PAIN; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PROGNOSIS; RESPIRATORY DISTRESS; RESPIRATORY TRACT INFECTION; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SINGLE DRUG DOSE; SMOKING; SURGICAL MORTALITY; SURVIVAL; TREATMENT PLANNING;

EID: 31044440377     PISSN: 10680640     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cpm.0000197344.91247.54     Document Type: Review

References (97)

1. World Cancer Report. WHO. International Agency for Research on Cancer. Lyon: IARC Press; 2003:182-187.
2. Surveillance, Epidemiology, and Results Program, 1973-1998. Bethesda, MD: Division of Cancer Control and Population Sciences, National Cancer Institute; 2001.
3. Deslauriers J, Ginsberg RJ, Piantadosi S, et al. Prospective assessment of 30-day operative morbidity for surgical resections in lung cancer. Chest. 1994;106:329s-330s.
4. Duque JL, Ramos G, Castrodeza J, et al. Early complications in surgical treatment of lung cancer: a prospective, multicenter study. Ann Thorac Surg. 1997;63:944-950.
5. Deslauriers J, Ginsberg RJ, Dubois P, et al. Current operative morbidity associated with elective surgical resection for lung cancer. CSJ. 1989; 32:335-338.
6. Wada H, Nakamura T, Nakamoto K, et al. Thirty-day operative mortality for thoracotomy in lung cancer. J Thorac Cardiovasc Surg. 1998; 115:70-73.
7. Yano T, Yokoyama H, Fukuyama Y, et al. The current status of postoperative complications and risk factors after a pulmonary resection for primary lung cancer. A multivariate analysis. Eur J Cardiothorac Surg. 1997;11:445-449.
8. Harpole DH, Liptay MJ, DeCamp MM, et al. Prospective analysis of pneumonectomy: risk factors for major morbidity and cardiac dysrhythmias. Ann Thorac Surg. 1996;61:977-982.
9. Mitsudomi T, Mitzoue T, Yoshimatsu T, et al. Postoperative complications after pneumonectomy for treatment of lung cancer: multivariate analysis. J Surg Oncol. 1996;61:218-222.
10. Raychaudhury T. Mortality of pulmonary resection for lung carcinoma. J R Coll Surg Edinb. 1983;28:182-187.
11. Ephgrave KS, Kleiman-Wexler R, Pfaller M, et al. Postoperative pneumonia: a prospective study of risk factors and morbidity. Surgery. 1993;114:815-821.
12. Stéphan F, Boucheseiche S, Hollande, et al. Pulmonary complications following lung resection. A comprehensive analysis of incidence and possible risk factors. Chest. 2000;118:1263-1270.
13. Vaporciyan AA, Merriman KW, Ece F, et al. Incidence of major pulmonary morbidity after pneumonectomy: association with timing of smoking cessation. Ann Thorac Surg. 2002;73:420-426.
14. Rodríguez de Castro F, Solé J, Caminero J. Neumonía nosocomial: epidemiología, factores de riesgo y pronóstico. Arch Bronconeumol. 1998;34(suppl 2):25-30.
15. NNIS Criteria for Determining Nosocomial Pneumonia. Atlanta: US Department of Health and Human Services, Centers for Disease Control and Prevention; 2003.
16. Ferdinand B, Shennib H. Postoperative pneumonia. Medical complications of thoracic surgery. Chest Surgery of North America. 1998;8:529-539.
17. Windsor JA, Hill GL. Risks factors for postoperative pneumonia. The importance of protein depletion. Ann Surg. 1988;208:209-214.
18. Iwamoto K, Ichiyama S, Shimokata K, et al. Postoperative pneumonia in elderly patients: incidence and mortality in comparison with younger patients. Intern Med. 1993;32:274-277.
19. Zeffren SE, Hartford CE. Comparative mortality for various surgical operations in older versus younger age groups. J Am Geriatr Soc. 1972; 20:485-549.
20. Mitsudomi T, Mitzoue T, Yoshimatsu T, et al. Postoperative complications after pneumonectomy for treatment of lung cancer: multivariate analysis. J Surg Oncol. 1996;61:218-222.
21. Busch E, Verazin G, Antkowiak JG, et al. Pulmonary complications in patients undergoing thoracotomy for lung carcinoma. Chest. 1994;105: 760-766.
22. Wahi R, McMurtrey MJ, DeCaro LF, et al. Determinants of perioperative morbidity and mortality after pneumonectomy. Ann Thorac Surg. 1989;48:33-37.
23. Huxley EJ, Virosla J, Gray WR, et al. Pharyngeal aspiration in normal adults and patients with depressed consciousness. Am J Med. 1978;64: 564-568.
24. Torres A, Aznar R, Gatell JM, et al. Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients. Am Rev Respir Dis. 1990;142:523-528.
25. Garibaldi RA, Britt MR, Coleman ML, et al. Risks factors for postoperative pneumonia. Am J Med. 1981;70:677-682.
26. Valenti VM, Trudell RG, Bentley DW. Factors predisposing to oropharyngeal colonization with Gram-negative bacilli in the aged. N Engl J Med. 1978;298:1108-1111.
27. Heatley RV, Williams RHP, Lewis MH. Preoperative intravenous feeding: a controlled trial. Postgrad Med J. 1979;55:541-545.
28. Ioanas M, Angrill J, Baldó X, et al. Bronchial bacterial colonization in patients with resectable lung carcinoma. Eur Respir J. 2002;19:326-332.
29. Pierce RJ, Copland JM, Sharpe K, et al. Preoperative risk evaluation for lung cancer resection: predicted postoperative product as a predictor of surgically mortality. Am J Respir Crit Care Med. 1994;150:947-955.
30. Bluman LG, Mosca L, Newman N, et al. Preoperative smoking habits and postoperative pulmonary complications. Chest. 1998;113:883-889.
31. Warner MA, Offord KP, Warner ME, et al. Role of preoperative cessation of smoking and others factors in postoperative pulmonary complications: a blinded prospective study of coronary artery bypass patients. Mayo Clin Proc. 1989;64:609-616.
32. Munday IT, Desai PM, Marshall CA, et al. The effectiveness of pre-operative advice to stop smoking: a prospective controlled trial. Anaesthesia. 1993;48:816-818.
33. Zeffren SE, Hartford CE. Comparative mortality for various surgical operations in older versus younger age groups. J Am Geriatr Soc. 1972;20:485-549.
34. Tisi GM. Preoperative evaluation of pulmonary function. Am Rev Respir Dis. 1979;119:293-310.
35. Pastorino U, Valente M, Bedini V, et al. Effect of chronic cardiopulmonary disease on survival after resection for stage Ia lung cancer. Thorax. 1982;37:680-683.
36. Nagashaki F, Flehinger BJ, Martini N. Complications of surgery in treatment of carcinoma of the lung. Chest. 1982;82:25-29.
37. Boushy SF, Billing DM, North LB, et al. Clinical course related to preoperative and postoperative pulmonary function in patients with bronchogenic carcinoma. Chest. 1971;59:383-391.
38. Lockwood P. Lung function test results and the risk of post-thoracotomy complications. Respiration. 1973;30:529-532.
39. Olsen GN, Block AJ, Swenson EW, et al. Pulmonary function evaluation of the lung resection candidate: a prospective study. Am Rev Respir Dis. 1975;111:379-387.
40. Kearney DJ, Lee TH, Reilly JJ, et al. Assessment of operative risk in patients undergoing lung resection. Importance of predicted pulmonary function. Chest. 1994;105:753-759.
41. Keagy BA, Lores ME, Starek PJK, et al. Elective pulmonary lobectomy: factors associated with morbidity and mortality. Ann Thorac Surg. 1985;40:349-352.
42. Wang J, Olak J, Ultmann RE, et al. assessment of pulmonary complications after lung resection. Ann Thorac Surg. 1999;67:1444-1447.
43. Bousamra M II, Presberg KW, Chammas JH, et al. Early and late morbidity in patients undergoing pulmonary resection with low diffusion capacity. Ann Thorac Surg. 1996;62:968-975.
44. Markos J, Mullan BP, Hillman DR, et al. Preoperative assessment as a predictor of mortality and morbidity after lung resection. Am Rev Respir Dis. 1989;139:902-910.
45. American College of Chest Physicians. Preoperative pulmonary function testing. Ann Intern Med. 1990;112:793-794.
46. Laros CD. Preoperative function analysis: possibilities and limits. Pneumologie. 1972;147:83-94.
47. Mittman C, Bruderman I. Lung cancer: to operate or not? Am Rev Respir Dis. 1977;116:477-496.
48. Pierce RJ, Copland JM, Sharpe K, et al. Preoperative risk evaluation for lung cancer resection: predicted postoperative product as a predictor of surgically mortality. Am J Respir Crit Care Med. 1994;150:947-955.
49. Eugene J, Brown SE, Light RW, et al. Maximum oxygen consumption: a physiologic guide to pulmonary resection. Surg Forum. 1982;33:260-262.
50. Brutsche MH, Siliopoulos A, Bolliger CT, et al. Exercise capacity and extent of resection as a predictors of surgical risk in lung cancer. Eur Respir J. 2000;15:828-832.
51. Bechard D, Wetstein L. Assessment of exercise oxygen consumption as preoperative criterion for lung resection. Ann Thorac Surg. 1987;44: 344-349.
52. Walsh GL, Morice RC, Putman JB Jr, et al. Resection of lung cancer is justified in high-risk patients selected by exercise oxygen consumption. Ann Thorac Surg. 1994;58:704-711.
53. Rao V, Todd TR, Kuus A, et al. Exercise oximetry versus spirometry in the assessment of risk prior to lung resection. Ann Thorac Surg. 1995; 60:603-609.
54. Bolliger CT, Perruchoud AP. Functional evaluation of the lung resection candidate. Eur Respir J. 1998;11:198-212.
55. Wansbrough-Jones MH, Nelson A, New L, et al. Bronchoalveolar lavage in the prediction of post-thoracotomy chest infection. Eur J Cardiothorac Surg. 1991;5:433-434.
56. Sok M, Dragas AZ, Erzen J, et al. Sources of pathogens causing pleuropulmonary infections after lung cancer resection. Eur J Cardiothorac Surg. 2002;22:23-29.
57. Joshi N, Ocalio AR, Harmony BH. A predictive index for nosocomial pneumonia in the intensive care unit. Am J Med. 1992;93:135.
58. Huxley EJ, Virosla J, Gray WR, et al. Pharyngeal aspiration in normal adults and patients with depressed consciousness. Am J Med. 1978;64: 564-568.
59. Craven DE, Kunches LM, Kilinsky, et al. Risks factors for pneumonia and fatality in patients receiving continuous mechanical ventilation. Am Rev Respir Dis. 1986;133:792-796.
60. Daschner F, Kappstein I, Reuschenbach K, et al. Stress ulcer prophylaxis and ventilation pneumonia: prevention by antibacterial cytoprotective agents? Infect Control Hosp Epidemiol. 1988;9:59-65.
61. Fagon JY, Chastre J, Hance AJ, et al. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med. 1993;94:281-288.
62. Fagon JY, Chastre J, Domart Y, et al. Nosocomial pneumonia in patients receiving continuous mechanical ventilation. Am Rev Respir Dis. 1989; 139:877-882.
63. Langer M, Mosconi P, Cigada M, et al. Long-term respiratory support and risk of pneumonia in critically ill patients. Am Rev Respir Dis. 1989;140:302-309.
64. Pereira W, Kovnat DM, Khan MA, et al. Fever and pneumonia after flexible fiberoptic bronchoscopy. Am Rev Respir Dis. 1975;112:59-64.
65. Craig DB. Postoperative recovery of pulmonary function. Anesth Analg. 1981;69:46-52.
66. James EC, Kolberg HL, Iwen GW, et al. Epidural analgesia for post-thoracotomy patients. J Thorac Cardiovasc Surg. 1981;82:898-903.
67. Bartlett RH, Brennan ML, Gazzaniga AB, et al. Studies on the pathogenesis and prevention of postoperative complications. Surg Gynecol Obstet. 1973;137:925-933.
68. Bonde P, McManus K, McAnespie M, et al. Lung surgery: identifying subgroup at risk for sputum retention. Eur J Cardiothorac Surg. 2002; 22:18-22.
69. Bonde P, Papachristos I, McCraith, et al. Sputum retention after lung operation: prospective, randomized trial shows superiority of prophylactic minitracheostomy in high-risk patients. Ann Thorac Surg. 2002;74: 196-203.
70. Shulman M, Sandler AN, Bradley JW, et al. Posthoracotomy pain and pulmonary function following epidural and systemic morphine. Anesthesiology. 1984;61:569-575.
71. Toledo-Pereyra LH, De Meester TR. Prospective randomized evaluation of intrathoracic intercostal nerve block with bupivacaine on postoperative ventilatory function. Ann Thorac Surg. 1979;27:203-205.
72. Sabanathan S, Mears AJ, Bickfort Smith PJ, et al. Efficacy of continuous extrapleural intercostal nerve block on post-thoracotomy pain and pulmonary mechanics. Br J Surg. 1990;77:221-225.
73. Ballantyne JC, Carr DB, deFerranti S, et al. The comparative effects of postoperative analgesia therapies on pulmonary outcome: cumulative meta-analyses of randomized controlled trial. Anesth Analg. 1998;86: 598-612.
74. Eghert LD, Battit GE. Reduction of postoperative pain by encouragement and instruction of patients. N Engl J Med. 1964;270:825-827.
75. Nagahiro I, Andou A, Aoe M, et al. Pulmonary function, postoperative pain, and serum cytokine level after lobectomy: a comparison of VATS and conventional procedure. Ann Thorac Surg. 2001;72:362-365.
76. Nomori H, Horio H, Naruke T, et al. What is the advantage of a thoracoscopic lobectomy over a limited thoracotomy procedure for lung cancer surgery? Ann Thorac Surg. 2001;72:879-884.
77. Kaseda S, Aoki T, Hangai, et al. Better pulmonary function and prognosis with video-assisted thoracic surgery than with thoracotomy. Ann Thorac Surg. 2000;70:1644-1646.
78. Nakata M, Saeki H, Yokoyama N, et al. Pulmonary function after lobectomy: video-assisted thoracic surgery versus thoracotomy. Ann Thorac Surg. 2000;70:938-941.
79. Société Fracaise d'Anesthésie et de Reanimation, Martin C, Group d'experts. Recomanations pour la pratique de l'antibioprophylaxie en chirugie. La Presse Médicale. 2001;30:794-802.
80. Osmon DR. Antimicrobial prophylaxis in adults. Mayo Clin Proc. 2000;75:98-109.
81. Rogers ML, Taylor R, Beggs FD. Antibiotic prophylaxis in general thoracic surgery in the UK. Eur J Cardiothorac Surg. 2000;18:375-376.
82. Culver DH, Horan TC, Gaynes RP, et al. Surgical wound infection rates by wound class, operative procedure and patient risk index. National Nosocomial Infections Surveillance System. Am J Med. 1991;91 (suppl 3B):S152-S157.
83. ASHP therapeutic guidelines on antimicrobial prophylaxis in surgery. Am J Health Syst Pharm. 1999;56:1839-1888.
84. Antimicrobial prophylaxis in surgery. Med Lett Drugs Ther. 1999;41: 75-79.
85. Mangram AJ, Horan TC, Pearson ML, et al. Guidelines for the prevention of surgical site infection. Infect Control Hosp Epidemiol. 1999;20: 247-280.
86. Garner JS. CDC guideline for prevention of surgical wound infections, 1985: supersedes guideline for prevention of surgical wound infections, published in 1982. Revised. Infect Control. 1986;7:193-200.
87. Simmons BP. Guideline for prevention of surgical wound infections. Infect Control. 1982;3:185-196.
88. Truesdale R, D'Alessandri R, Manuel G, et al. Antimicrobial vs placebo prophylaxis in noncardiac thoracic surgery. JAMA. 1979;241:1254-1256.
89. Aznar R, Mateu M, Miró JM, et al. Antibiotic prophylaxis in non-cardiac thoracic surgery: cefazolin versus placebo. Eur J Cardiothorac Surg. 1991;5:515-518.
90. Frimodt-Moller P, Ostri P, Pedersen KR, et al. Antibiotic prophylaxis in pulmonary surgery. Ann Surg. 1981;195:444-450.
91. Ilves R, Cooper JD, Tood J, et al. Prospective randomized double-blind study using prophylactic cephalothin for major elective general thoracic operations. J Thorac Cardiovasc Surg. 1981;81:813-817.
92. Wertzel H, Swoboda L, Joos-Würtemberger, et al. Perioperative antibiotic prophylaxis in general thoracic surgery. Thorac Cardiovasc Surg. 1992;40:326-329.
93. Tarkka M, Okela R, Lepojärvi, et al. Infection prophylaxis in pulmonary surgery: randomized prospective study. Ann Thorac Surg. 1987;44:508-513.
94. Bernard A, Pillet M, Goudet P, et al. Antibiotic prophylaxis in pulmonary surgery. A prospective randomized double-blind trial of flash cefuroxime versus forty-eight-hour cefuroxime. J Thorac Cardiovasc Surg. 1994;107:896-900.
95. Train M, Soulard D, Bouyer L, et al. Comparaison de l'amoxicilline et du céfamandol pour la prévention des infections broncho-pulmonaires en chirurgie pulmonaire. Ann Fr Anesth Rèanim. 1994;13:280-284.
96. Boldt J, Piper S, Uphus D, et al. Preoperative microbiologic screening and antibiotic prophylaxis in pulmonary resection operations. Ann Thorac Surg. 1999;68:208-211.
97. Carrel TP, Eisinger E, Vogt M, et al. Pneumonia after cardiac surgery is predictable by tracheal aspirates but cannot be prevented by prolonged antibiotic prophylaxis. Ann Thorac Surg. 2001;72:143-148.